All In Biotech

Drug Trial Radar · NCT00489424

Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass

A Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study of Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an i.v. Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass

Last checked: Nov 19, 2026Latest source record: Feb 18, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 793 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

793

Actual

Start

Jun 2007

Primary completion

Dec 2007

Study completion Dec 2007

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Jun 21, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Female only, from 45 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy of acetaminophen or fluvastatin in reducing the rate of occurrence and the severity of post dose symptoms that may occur during the 3 day period following a zoledronic acid infusion in post menopausal women with low bone mass.

Conditions

  • Osteoporosis

Interventions

  • PlaceboDrug

  • AcetaminophenDrug

  • FluvastatinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Patients With a Clinically Significant Increase in Oral Body Temperature or Use of Rescue Medication.Time frame: 0 - 3 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Refer to the E-portal link for ZOL446HUS136

    Http://www.osteoporosisclinicalresearch.com, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.